Dihexa Price Comparison

Live prices from 2 SA suppliers, from R550.00, compared side by side so you never overpay.

Neuropeptides & sleep research Prices checked
We compare prices & may earn a commission. We do not sell or supply any products. Full disclosure.

We may earn a commission from the suppliers listed here. Read our full disclosure.

Best Price R550.00
Average R725.00
Highest R900.00
You Could Save 39%
2 results
Best Price
Save 39%
Crono Pharm logo

Dihexa

In Stock 10mg Lab Tested
R550.00
+ R150.00 delivery
Buy Peptides logo

Dihexa 10mg

R900.00
In Stock 10mg
+ R250.00 delivery

Compare another peptide

PeptideSupermarket® compares prices but doesn't sell products.

All purchases are made directly from third-party suppliers; your relationship is solely with them. We accept no liability for the quality, purity, or legality of any products listed.

We may earn a commission when you click through to a supplier and make a purchase. This does not affect pricing information displayed.

By using this site you accept responsibility for ensuring purchases comply with applicable laws in your jurisdiction. Read our full disclosure.

Dihexa Profile

Emerging

Synaptogenic Peptide | Cognitive Enhancement

Overview

Dihexa is a synthetic oligopeptide derived from angiotensin IV that potently enhances cognitive function by promoting synaptogenesis. It is 10 million times more potent than BDNF at promoting synapse formation through HGF/c-Met receptor activation.

Mechanism of Action

Binds to hepatocyte growth factor (HGF) with high affinity (Kd = 65 pM) and potentiates its activity at c-Met receptor, activating PI3K/AKT pathways and promoting new synaptic connections with extraordinary potency.

Key Benefits

  • Dramatic synaptogenesis promotion
  • 10 million times more potent than BDNF
  • Cognitive enhancement and memory improvement
  • Neuroprotection and potential neuroregeneration
  • Applications for Alzheimer's, TBI, age-related cognitive decline
  • Oral bioavailability

Quick Stats

Typical Dose
8-10mg oral or 2-5mg injectable (0.5mg/kg based on research)
Frequency
Once daily in the morning
Cycle Duration
4-8 weeks on
Storage
Oral: room temperature (2 year shelf life); Injectable lyophilized: 2-8°C; Reconstituted: 2-8°C, use within 30 days

Molecular Information

Molecular Weight
504.7 Da
Type
Modified oligopeptide
Half-Life
8-12 days

Amino Acid Sequence

Hexanoyl-Tyr-Ile-Ahx-NH2

Modifications

N-terminal hexanoic acid for BBB penetration Enhanced metabolic stability Kd = 65 pM for HGF binding

Research Indications

The following information is derived from published scientific literature and is provided for educational and research reference purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. These peptides are not approved for human use and are sold exclusively for in-vitro laboratory research.

Memory Enhancement

Most Effective

Improvements in spatial, working, and consolidation demonstrated across animal models.

Learning Acceleration

Most Effective

Enhanced acquisition through increased synaptic plasticity.

Cognitive Recovery

Effective

Restoration in impairment models including scopolamine-induced amnesia.

Amyloid Reduction

Effective

Reduced amyloid burden in Alzheimer's models.

Neuroinflammation Reduction

Effective

Decreased neuroinflammation and glial activation.

Synaptic Preservation

Effective

Protection of synapses in neurodegeneration models.

Dendritic Spine Formation

Moderate

3-fold increase in dendritic spine formation demonstrated.

BDNF Upregulation

Moderate

Increases brain-derived neurotrophic factor expression.

Angiogenesis Promotion

Moderate

Promotes new blood vessel formation in brain.

Dosing Protocols

oral

Oral capsules/tablets are the most convenient form. Take in the morning with or without food. No reconstitution required.

Goal Dose Frequency Route
Standard cognitive enhancement 8-10mg 1x daily (morning) Oral
Low-dose maintenance 5mg 1x daily Oral
Intensive learning protocol 10-15mg 1x daily Oral

Key Tips

  • No injection required
  • Room temperature storage (2 year shelf life)
  • Convenient once-daily dosing

injectable

Subcutaneous/intraperitoneal injection provides more consistent dosing. Requires refrigerated storage after reconstitution.

Goal Dose Frequency Route
Research protocol 0.5mg/kg daily Daily or 3x weekly SubQ/IP
Standard injectable 2-5mg total 1x daily SubQ

Key Tips

  • Abdomen, thigh, or upper arm injection sites
  • More consistent dosing than oral
Materials Needed
Dihexa lyophilized powder Bacteriostatic water Insulin syringes Alcohol swabs
Steps
  1. 1 Calculate water volume for desired concentration
  2. 2 Add bacteriostatic water slowly to lyophilized powder
  3. 3 Gently swirl to dissolve - do not shake
  4. 4 Store reconstituted solution in refrigerator
  5. 5 Use within 30 days of reconstitution

topical

Topical cream formulation with limited research data. Experimental route.

Goal Dose Frequency Route
Topical application 10-20mg cream 1x daily Inner forearms, shoulders (rotate sites)

Key Tips

  • Non-invasive
  • Room temperature storage

Peptide Interactions

Semax

Compatible

Enhanced cognitive benefits; monitor for overstimulation.

Selank

Compatible

Synergistic effects; watch for neural overstimulation.

BPC-157

Compatible

Different mechanisms; no negative interactions known.

P21

Avoid

Both affect neuroplasticity strongly; avoid concurrent use.

Noopept

Compatible

Some stack for cognition; limited safety data.

NAD+

Compatible

Complementary mechanisms for cellular health.

Cerebrolysin

Monitor

Both potently neuroactive; may cause overstimulation.

TB-500

Compatible

Different targets; no known interactions.

What to Expect

Week 1-2

Subtle cognitive shifts; possible headaches during adaptation

Week 2-4

Improved focus and memory formation

Week 4-8

Peak cognitive benefits and enhanced learning

Post-cycle

Effects may persist for days to weeks after discontinuation

Side Effects & Safety

Common Side Effects

  • Headaches (most frequent side effect)
  • Anxiety or overstimulation
  • Sleep disruption when dosed late in day
  • Mental clarity increase

Monitoring

  • Cognitive function assessment
  • Mood and anxiety levels
  • Sleep quality
  • Requires cycling to prevent tolerance

Stop Signs

  • Severe or persistent headaches
  • Increasing anxiety or panic attacks
  • Significant mood changes or depression
  • Sleep disturbance beyond 3 days
  • Concerning neurological symptoms
  • Signs of overstimulation or mania
  • Injection site reactions (if injectable)

Contraindications

  • Not FDA approved - research compound only
  • Theoretical cancer risk via c-Met activation
  • Cancer history (avoid due to c-Met pathway)
  • Pregnancy or breastfeeding
  • No long-term human safety data

Quality Checklist

Good Signs

  • Pharmaceutical-grade from licensed compounding pharmacy
  • Certificate of analysis showing >98% purity
  • Proper storage conditions maintained
  • Uniform capsules with clear lot numbers and expiration dates

Warning Signs

  • Research chemical sources may lack pharmaceutical standards
  • Products lacking third-party testing documentation

Bad Signs

  • No analytical testing or purity reports
  • Unverified sources
  • Suspicious or extremely cheap pricing
  • Discolored or damaged capsules

Research & References

Latest Research

2024

Fosgonimeton (ATH-1017) Phase 2 Trials

Clinical Development

Phosphate pro-drug of Dihexa currently in Phase 2 clinical trials for Alzheimer's and Parkinson's disease.

Key References

  1. 2013

    Injectable Route Efficacy Study

    Intraperitoneal injection at 0.5mg/kg/day completely reversed scopolamine-induced cognitive deficits (p<0.001), with performance indistinguishable from healthy controls.

  2. 2021

    APP/PS1 Alzheimer's Model Study

    Dihexa restored spatial learning and memory in Morris water maze tests, increased neuronal cells and synaptophysin expression, reduced neuroinflammation.

  3. 2014

    Synaptogenic Potency Study

    Demonstrated to be 10 million times more effective than BDNF at promoting synapse formation through HGF/c-Met receptor activation.

Search PubMed for Dihexa

Get Peptide Price-drop Alerts

Be the first to know when prices drop on your favourite peptides

No spam. Unsubscribe anytime. We respect your privacy.